Your browser doesn't support javascript.
loading
Impact of conditioning regimen intensity on the outcomes of peripheral T-cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T-cell lymphoma patients undergoing allogeneic transplant.
Savani, Malvi; Ahn, Kwang W; Chen, Yue; Ahmed, Sairah; Cashen, Amanda F; Shadman, Mazyar; Modi, Dipenkumar; Khimani, Farhad; Cutler, Corey S; Zain, Jasmine; Brammer, Jonathan E; Rezvani, Andrew R; Fenske, Timothy S; Sauter, Craig S; Kharfan-Dabaja, Mohamed A; Herrera, Alex F; Hamadani, Mehdi.
  • Savani M; Division of Hematology/Oncology, Department of Medicine, University of Arizona and University of Arizona Cancer Center, Tucson, Arizona, USA.
  • Ahn KW; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Chen Y; Department of Medicine, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Ahmed S; Department of Medicine, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Cashen AF; Division of Cancer Medicine, Departments of Lymphoma/Myeloma and Stem Cell Transplantation, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Shadman M; Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA.
  • Modi D; Department of Medicine, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Khimani F; Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA.
  • Cutler CS; Division of Hematology-Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA.
  • Zain J; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Brammer JE; Department of Stem Cell Transplantation and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Rezvani AR; Department of Hematology and Hematopoietic Stem Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA.
  • Fenske TS; Division of Hematology, Department of Medicine, Ohio State University, Columbus, Ohio, USA.
  • Sauter CS; Division of Blood & Marrow Transplantation, Department of Medicine, Stanford University, Stanford, California, USA.
  • Kharfan-Dabaja MA; BMT & Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Herrera AF; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York, USA.
  • Hamadani M; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida, USA.
Br J Haematol ; 197(2): 212-222, 2022 04.
Article en En | MEDLINE | ID: mdl-35106754
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células T Periférico / Linfoma Anaplásico de Células Grandes / Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped / Linfadenopatía Inmunoblástica Tipo de estudio: Observational_studies Límite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células T Periférico / Linfoma Anaplásico de Células Grandes / Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped / Linfadenopatía Inmunoblástica Tipo de estudio: Observational_studies Límite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Año: 2022 Tipo del documento: Article